Citadel Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-7,200
| Closed | -$195K | – | 15559 |
|
|
2024
Q2 | $195K | Sell |
7,200
-2,800
| -28% | -$58.2K | ﹤0.01% | 9980 |
|
|
2024
Q1 | $183K | Sell |
10,000
-1,800
| -15% | -$28.6K | ﹤0.01% | 10452 |
|
|
2023
Q4 | $145K | Sell |
11,800
-14,400
| -55% | -$135K | ﹤0.01% | 10441 |
|
|
2023
Q3 | $393K | Buy |
26,200
+24,900
| +1,915% | +$518K | ﹤0.01% | 8600 |
|
|
2023
Q2 | $42.2K | Sell |
1,300
-300
| -19% | -$11K | ﹤0.01% | 12010 |
|
|
2023
Q1 | $62.6K | Buy |
1,600
+800
| +100% | +$39.1K | ﹤0.01% | 11870 |
|
|
2022
Q4 | $42.3K | Sell |
800
-5,900
| -88% | -$287K | ﹤0.01% | 12342 |
|
|
2022
Q3 | $302K | Sell |
6,700
-11,700
| -64% | -$503K | ﹤0.01% | 9576 |
|
|
2022
Q2 | $670K | Buy |
18,400
+12,200
| +197% | +$443K | ﹤0.01% | 7992 |
|
|
2022
Q1 | $256K | Buy |
+6,200
| New | +$218K | ﹤0.01% | 10952 |
|
|
2021
Q4 | – | Sell |
-8,400
| Closed | -$462K | – | 14992 |
|
|
2021
Q3 | $462K | Buy |
+8,400
| New | +$440K | ﹤0.01% | 10069 |
|
|
2020
Q4 | – | Sell |
-3,600
| Closed | -$242K | – | 11661 |
|
|
2020
Q3 | $242K | Sell |
3,600
-2,200
| -38% | -$120K | ﹤0.01% | 8500 |
|
|
2020
Q2 | $243K | Buy |
+5,800
| New | +$223K | ﹤0.01% | 8255 |
|
|
2020
Q1 | – | Sell |
-5,300
| Closed | -$214K | – | 10332 |
|
|
2019
Q4 | $214K | Buy |
+5,300
| New | +$186K | ﹤0.01% | 8072 |
|
Other funds holding SILK
Citadel Advisors's SILK Position: Q3 2024 in Review
Citadel Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 285,886 shares — an estimated $7.73M sold.
Citadel Advisors first reported a position in SILK in Q2 2019 and held it in 19 quarters. The position peaked at $22.1M in Q1 2023. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- Citadel Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Citadel Advisors sold 285,886 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $7.73M.
- Citadel Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 19 quarters.
- Citadel Advisors's Silk Road Medical, Inc. Common Stock position peaked at $22.1M in Q1 2023.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.